Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

XERIS PHARMACEUTICALS INC (XERS)

Cash Flow Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsJun-30-21Mar-31-21Dec-31-20Sep-30-20Jun-30-20Jun-05-20Mar-31-20Mar-05-20
   10-Q8-K10-K10-Q10-Q8-K10-Q8-K
Net income  -83.8-80.5-91.3-102.9-119.8 -129.9 
Depreciation and amortization    1.51.41.4 1.3 
Stock-based compensation    8.38.07.7 7.3 
Change in working capital   [+]  15.521.427.8 38.3 
Other operating activities    -14.5-27.1-30.0 -29.1 
Cash from operations    -80.6-99.3-112.9 -112.1 
   
Capital expenditures    -0.4-0.4-0.8 -0.9 
Purchases of short-term investments    -101.8     
Other cash from investing    74.759.2117.7 128.4 
Cash from investing    -27.4-43.714.5 25.0 
   
Issuance of common stock, net     67.664.6 44.5 
Option exercises  0.9 0.80.80.8   
Financing costs    -5.6-5.6-6.9   
Other cash from financing    55.452.363.4 18.2 
Cash from financing    126.1124.7134.2 64.5 
   
Free cash flow    -80.9-99.7-113.6 -113.1 
        Per share (diluted)    ($2.03)($2.79)($3.67) ($4.01) 
   
Cash paid for interest  5.0 4.64.64.9 4.5 

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy